Early Detection of Vaping-related Vascular Diseases
University of Miami · with Florida Department of Health · NCT05454267
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–40 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- September 12, 2022
- Record last updated
- May 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.
Conditions: Vaping; Blood Vessel Injury
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Vapers Group
- Current electronic cigarette (EC) Puff Bar users defined as using EC either daily or occasionally in the past 30 days for at least 6 months, and with 5% nicotine concentration pods.
- Adults aged 18-40 years
Healthy Group
- Healthy never smokers, never vapers
- Adults aged 18-40 years
Exclusion Criteria
- Current or past smoking of tobacco cigarette (TC) or other tobacco/nicotine products (e.g., smokeless tobacco, Hookah) or marijuana will be excluded from the study.
- Subjects with self-reported history of chronic health problems including asthma, chronic obstructive pulmonary disease (COPD), morbid obesity (BMI>40 kg/m2), hypertension or diabetes
- Pregnant or breastfeeding women
Recruiting US locations
University of Miami Health System
Miami, FL 33136
Site contact: Michael Campos, MD · 3052436388 · mcampos1@med.miami.edu
Study contacts (from the official record)
- Adam Wanner, MD · (305)243-2568 · awanner@med.miami.edu
- Michael Campos, MD · 3052436388 · mcampos1@med.miami.edu
Similar studies in Florida
All heart & blood pressure studies in Florida →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Orlando, FL + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
Shanghai CureGene Pharmaceutical Co., Ltd.
- Location
- Miami, FL
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Novartis Pharmaceuticals
- Location
- Bradenton, FL + 4 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Clearwater, FL + 30 other US sites
- Eligibility basics
- Ages 65+